Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SKYE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 4,528 | $1.61 | $7,290 Sale | Form 4 ↗ |
| Sep 23, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 114,851 | $1.61 | $184.9K Sale | Form 4 ↗ |
| Sep 23, 2026 | 5AM Ventures II LP 10% owner | SKYE Skye Bioscience, Inc. | Sale | 4,528 | $1.61 | $7,290 Sale | Form 4 ↗ |
| Sep 23, 2026 | 5AM Ventures II LP 10% owner | SKYE Skye Bioscience, Inc. | Sale | 114,851 | $1.61 | $184.9K Sale | Form 4 ↗ |
| Sep 22, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,088 | $1.65 | $1,795 Sale | Form 4 ↗ |
| Sep 22, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 27,612 | $1.65 | $45.6K Sale | Form 4 ↗ |
| Sep 22, 2026 | 5AM Ventures II LP 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,088 | $1.65 | $1,795 Sale | Form 4 ↗ |
| Sep 22, 2026 | 5AM Ventures II LP 10% owner | SKYE Skye Bioscience, Inc. | Sale | 27,612 | $1.65 | $45.6K Sale | Form 4 ↗ |
| Sep 16, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,285 | $1.91 | $2,454 Sale | Form 4 ↗ |
| Sep 16, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 32,607 | $1.91 | $62.3K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kush Parmar 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,285 | $1.91 | $2,454 Sale | Form 4 ↗ |
| Sep 16, 2026 | Kush Parmar 10% owner | SKYE Skye Bioscience, Inc. | Sale | 32,607 | $1.91 | $62.3K Sale | Form 4 ↗ |
| Aug 20, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 6,495 | $0.32 | $2,078 Sale | Form 4 ↗ |
| Aug 20, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 46 | $0.32 | $14.72 Sale | Form 4 ↗ |
| Aug 20, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,159 | $0.32 | $371 Sale | Form 4 ↗ |
| Aug 20, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 6,495 | $0.32 | $2,078 Sale | Form 4 ↗ |
| Aug 20, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 46 | $0.32 | $14.72 Sale | Form 4 ↗ |
| Aug 20, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,159 | $0.32 | $371 Sale | Form 4 ↗ |
| Aug 19, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 57,476 | $0.35 | $20.1K Sale | Form 4 ↗ |
| Aug 19, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 409 | $0.35 | $143 Sale | Form 4 ↗ |
| Aug 19, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 10,255 | $0.35 | $3,589 Sale | Form 4 ↗ |
| Aug 19, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 57,476 | $0.35 | $20.1K Sale | Form 4 ↗ |
| Aug 19, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 409 | $0.35 | $143 Sale | Form 4 ↗ |
| Aug 19, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 10,255 | $0.35 | $3,589 Sale | Form 4 ↗ |
| Aug 18, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 253,080 | $0.38 | $96.2K Sale | Form 4 ↗ |
| Aug 18, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,830 | $0.38 | $695 Sale | Form 4 ↗ |
| Aug 18, 2026 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 45,090 | $0.38 | $17.1K Sale | Form 4 ↗ |
| Aug 18, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 253,080 | $0.38 | $96.2K Sale | Form 4 ↗ |
| Aug 18, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 1,830 | $0.38 | $695 Sale | Form 4 ↗ |
| Aug 18, 2026 | 5AM Partners II, LLC 10% owner | SKYE Skye Bioscience, Inc. | Sale | 45,090 | $0.38 | $17.1K Sale | Form 4 ↗ |
| Aug 22, 2025 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 6,470 | $3.42 | $22.1K Sale | Form 4 ↗ |
| Aug 22, 2025 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 163,979 | $3.42 | $560.8K Sale | Form 4 ↗ |
| Aug 22, 2025 | Scott M. Rocklage 10% owner | SKYE Skye Bioscience, Inc. | Sale | 6,470 | $3.42 | $22.1K Sale | Form 4 ↗ |
| Aug 22, 2025 | Scott M. Rocklage 10% owner | SKYE Skye Bioscience, Inc. | Sale | 163,979 | $3.42 | $560.8K Sale | Form 4 ↗ |
| Aug 21, 2025 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 2,314 | $3.57 | $8,261 Sale | Form 4 ↗ |
| Aug 21, 2025 | Andrew J. Schwab Director, 10% owner | SKYE Skye Bioscience, Inc. | Sale | 58,642 | $3.57 | $209.4K Sale | Form 4 ↗ |
| Aug 21, 2025 | Scott M. Rocklage 10% owner | SKYE Skye Bioscience, Inc. | Sale | 2,314 | $3.57 | $8,261 Sale | Form 4 ↗ |
| Aug 21, 2025 | Scott M. Rocklage 10% owner | SKYE Skye Bioscience, Inc. | Sale | 58,642 | $3.57 | $209.4K Sale | Form 4 ↗ |
| Nov 18, 2024 | Kaitlyn Arsenault Chief Financial Officer | SKYE Skye Bioscience, Inc. | Sale | 43,026 | $4.99 | $214.7K Sale | Form 4/A ↗ |
| Nov 18, 2024 | Tuan Tu Diep Chief Development Officer | SKYE Skye Bioscience, Inc. | Sale | 19,489 | $4.99 | $97.3K Sale | Form 4 ↗ |
| Nov 18, 2024 | Punit Dhillon Chief Executive Officer, Director | SKYE Skye Bioscience, Inc. | Sale | 82,546 | $4.99 | $411.9K Sale | Form 4 ↗ |
| Nov 18, 2024 | Paul A. Grayson Director | SKYE Skye Bioscience, Inc. | Sale | 86,244 | $4.99 | $430.4K Sale | Form 4 ↗ |
| Nov 15, 2024 | Kaitlyn Arsenault Chief Financial Officer | SKYE Skye Bioscience, Inc. | Sale | 190 | $5.55 | $1,055 Sale | Form 4/A ↗ |
| Nov 15, 2024 | Tuan Tu Diep Chief Development Officer | SKYE Skye Bioscience, Inc. | Sale | 85 | $5.55 | $472 Sale | Form 4 ↗ |
| Nov 15, 2024 | Punit Dhillon Chief Executive Officer, Director | SKYE Skye Bioscience, Inc. | Sale | 364 | $5.55 | $2,020 Sale | Form 4 ↗ |
| Nov 15, 2024 | Paul A. Grayson Director | SKYE Skye Bioscience, Inc. | Sale | 307 | $5.55 | $1,704 Sale | Form 4 ↗ |
46 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances